Use of the cathelicidin LL-37 and derivatives thereof for wound healing
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 18, 2008
Grant Date -
Jun 28, 2007
app pub date -
Jan 28, 2004
filing date -
Jan 29, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Use of the antimicrobial cathelicidin peptide ll-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithalial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully